Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Reprod Biomed ; 16(6): 417-420, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30123871

ABSTRACT

BACKGROUND: Ovarian superovulation and increased follicle-stimulating hormone concentration for infertility treatment may be the risk factors of developed granulosa-cell tumor. The aim of this report is to introduce a case of granulosa-cell tumor which was discovered after ovarian stimulation. CASE: A 31-yr-old woman with clinical presentation of massive abdominal distention was referred to the gynecology and oncology department of an academic hospital, Mashhad University of Medical Sciences in Aug 2017. She had the history of secondary infertility and was undergoing In Vitro Fertilization protocol and ovarian stimulation, but, the cycle was canceled. The patient suffered from gradual abdominal distention one month after the end of IVF procedure despite pregnancy failure. 2-3 months after management of the ovarian hyperstimulation syndrome, investigation revealed large ovarian mass and increased tumor marker inhibin. Exploratory laparotomy was performed and revealed stage III ovarian cancer. The final pathology report indicated juvenile granulosa cell tumor. So, optimal surgical staging and cytoreductive surgery without fertility preserving were perfumed. Chemotherapy was recommended due to the advanced stage of ovarian cancer. Unfortunately, she experienced metastatic diseases in pelvic and abdomen in less than six months; and currently is receiving the second and third line chemotherapy. CONCLUSION: Persistent ovarian enlargement or ascites during or after infertility treatment should be carefully considered and managed.

2.
Electron Physician ; 10(7): 7095-7100, 2018 Jul.
Article in English | MEDLINE | ID: mdl-30128101

ABSTRACT

BACKGROUND: Increased subcutaneous fat thickness and depth of target organs in over-obese patients, results in weak signals and inadequate images. Tissue harmonic imaging has been used widely in obese patients and is believed to result in higher quality images. This superiority is not proved in modern machines with improved image quality in conventional mode. OBJECTIVE: To compare the image quality between conventional and tissue harmonic ultrasound images. METHODS: This cross-sectional study was carried out from March 2015 to June 2016. Seventy-six over-obese patients referred to Ghaem Hospital (Mashhad, Iran) for weight-correction surgeries, were enrolled into the study. Conventional and tissue harmonic images of their kidneys were blinded and compared back-to-back by four expert radiologists. Data were analyzed by SPSS version 16, using Cochrane's Q test. RESULTS: All raters reported image quality to be better in tissue harmonic compared to fundamental frequency ultrasound (p=0.000, Cochrane's Q test). Although better image quality in tissue harmonic mode was reported by the four raters, there was weak inter-observer agreement (p=0.081 for right kidney and p=0.21 for left kidney). CONCLUSION: Advances in ultrasound equipment and the introduction of tissue harmonic imaging can improve the diagnostic performance in over-obese patients and this mode of imaging should be used whenever evaluating over-obese subjects.

3.
Iran J Otorhinolaryngol ; 28(88): 305-312, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27738606

ABSTRACT

INTRODUCTION: Different imaging modalities are used to evaluate salivary gland diseases, including tumors. Ultrasonography (US) is the preferred method on account of its ease of use, affordability, safety profile, and good tolerance among patients. The aim of this study was to evaluate the role of US in differentiating malignant from benign parotid tumors, in the context of previous controversy in the literature on this subject. MATERIALS AND METHODS: A cross-sectional study was performed in patients who presented to Qaem Medical Center with parotid masses and who were candidates for parotidectomy between June 2013 and January 2015. Patients were initially referred for a diagnostic US of the parotid. US examinations were performed and sonographic features were reported. The tumors were then classified as benign or malignanton the basis of literature descriptions of the US features of parotid tumors, and were next diagnosed pathologically. The sensitivity, specificity, positive predictive value, and negative predictive value of US for the purpose of differentiating malignant from benign tumors were then calculated. RESULTS: Twenty-eight patients (aged 18-92 years) underwent US of parotid masses. Twenty-three tumors were diagnosed as benign and five were diagnosed as malignant. The final histopathologic examination showed 21 benign and seven malignant tumors. The sensitivity, specificity, positive predictive value, and negative predictive value of US for differentiating malignant from benign tumors were calculated as 57%, 95%, 80%, and 87%, respectively. CONCLUSION: US has a high specificity in differentiating between malignant and benign tumors. However, fine needle aspiration or core needle biopsy is advocated for an exact diagnosis.

4.
Nucl Med Commun ; 36(12): 1202-7, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26426965

ABSTRACT

INTRODUCTION: Although radioiodine therapy (RIT) has been used for the treatment of hyperthyroidism for many decades, there is no consensus on the optimal time of methimazole (MMI) discontinuation before RIT. The aim of this clinical trial is to study the effect of three different time points of MMI discontinuation on response to RIT. METHOD AND PATIENTS: Overall, 151 patients (18-65 years old), with Graves' disease who were taking MMI and referred to I-131 therapy, were consecutively assigned to one of three groups, and MMI was discontinued for 24-48, 48.1-72, and 72.1-168 h in group, 1, 2, and 3, respectively. Radioiodine uptake was measured in all patients and the radioiodine dose was calculated according to the Quimby formula to deliver 7.4 MBq of I-131 per gram of thyroid weight. Response to RIT was assessed at 1, 3, 6, and 12 months after RIT. RESULTS: A total of 102 women and 49 men were included in the study. The mean administered dose of I-131 was 362.9±188.7 MBq (9.8±5.1 mCi) and the mean time to response for radioiodine was 4.1±3.6 months. There was no significant difference between the three groups in age, thyroid weight, anti-TPO level, radioactive iodine uptake level, and radioiodine dose (P>0.1). Response to RIT at 1, 3, 6, and 12 months after administration was also not different between the three groups (P>0.57). CONCLUSION: No difference was found in the response to treatment between patients with MMI discontinuation for 24-48, 48.1-72, and 72.1-96 h before RIT. Shorter discontinuation of MMI before RIT may be preferable in most patients. Video Abstract: http://links.lww.com/NMC/A39.


Subject(s)
Graves Disease/drug therapy , Graves Disease/radiotherapy , Iodine Radioisotopes/therapeutic use , Methimazole/therapeutic use , Withholding Treatment , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Time Factors , Young Adult
5.
J Craniofac Surg ; 24(2): e108-12, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23524800

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate of ultrasonographic findings of masseter muscle in females with temporomandibular disorders. Sonographic features were compared in those with myofacial pain disorder (MPD) and temporomandibular click, as well as healthy women. METHODS: Sixty-three females referred to the Prosthetic Department of Dental Faculty of Mashhad University of Medical Sciences (22 with MPD, 21 with click, and 20 control subjects) aged from 20 to 40 years were evaluated. The masseter muscle thickness in each group was measured bilaterally at rest and maximum contraction by a real-time ultrasound imaging technique. The type of the internal pattern of the masseter muscle in sonography was classified to 3 types (I, II, and III) according to the visibility, widths, and echogenicity of internal echogenic bands. RESULTS: In the right-side masseter, thickness in the control group was greater than that in the MPD group (P = 0.033). There was no significant difference about the thickness of the masseter at rest and at maximum contraction between both sides in control and MPD groups; however, in the click group, the difference was significant. Also, the muscle thickness of either right or left side at rest and at maximum contraction was significant. There was a significant difference between control and MPD groups (P < 0.001) as well as MPD and click groups (P < 0.001) in the type of the internal pattern. CONCLUSIONS: There were obvious ultrasonographic changes of the masseter muscle in females with MPD, which might be related to the muscle inflammation.


Subject(s)
Masseter Muscle/diagnostic imaging , Temporomandibular Joint Disorders/diagnostic imaging , Adult , Case-Control Studies , Facial Pain/diagnostic imaging , Facial Pain/physiopathology , Female , Humans , Masseter Muscle/physiopathology , Muscle Contraction/physiology , Temporomandibular Joint Disorders/physiopathology , Ultrasonography
6.
Arch Iran Med ; 10(4): 514-8, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17903058

ABSTRACT

BACKGROUND: Congenital glucose-galactose malabsorption is a rare autosomal recessive disorder of the intestinal transport of glucose and galactose, leading to watery diarrhea, dehydration, failure to thrive, and early death. METHODS: In this study, we analyzed D28G mutation in 16 family members of a patient with typical presentation of congenital glucose-galactose malabsorption with polymerase chain reaction-Restriction Fragment Length Polymorphism method. RESULTS: Nine members of this family were heterozygous for D28G mutation. CONCLUSION: To the best of our knowledge this is the first report of D28G mutation in Iran. Moreover, this simple typical PCR-Restriction Fragment Length Polymorphism method, allows immediate identification of D28G mutation.


Subject(s)
Aspartic Acid/genetics , Galactose/metabolism , Glucose/metabolism , Glycine/genetics , Malabsorption Syndromes/congenital , Malabsorption Syndromes/genetics , Mutation/genetics , Sodium-Glucose Transporter 1/genetics , Female , Humans , Infant, Newborn , Male , Pedigree , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length
SELECTION OF CITATIONS
SEARCH DETAIL